Evommune grants stock options to legal chief
Evommune, Inc. reported that Chief Business & Legal Officer Gregory S. Moss received an option grant for 115,279 shares of common stock at an exercise price of $26.77 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Evommune, Inc. reported that Chief Business & Legal Officer Gregory S. Moss received an option grant for 115,279 shares of common stock at an exercise price of $26.77 per share. The options expire on April 15, 2036 and represent his entire reported option position from this grant.
According to the vesting terms, one fourth of the shares will vest on the first anniversary of the grant date, and the remaining shares will vest in 36 equal monthly installments thereafter, subject to his continuous service with the company.
Insider Trade Summary
Grant/Award: 115,279 shares
Grant/Award
1 txn
Insider
Moss Gregory S.
Role
Chief Business & Legal Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Buy) | 115,279 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Buy) — 115,279 contracts (Direct)
Footnotes (1)
- F1. One fourth (1/4) of the shares subject to the option award shall vest on the first anniversary of the grant date and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
Key Figures
Option Grant Size: 115,279 shares
Exercise Price: $26.77 per share
Total Options After Grant: 115,279 options
+3 more
6 metrics
Option Grant Size
115,279 shares
Employee stock option grant to Chief Business & Legal Officer
Exercise Price
$26.77 per share
Stock option exercise price for the 115,279-share grant
Total Options After Grant
115,279 options
Total derivative securities held following the reported transaction
Expiration Date
April 15, 2036
Option expiration for the 115,279-share grant
Initial Vesting Portion
25% of shares
One fourth vests on the first anniversary of the grant date
Remaining Vesting Schedule
36 monthly installments
Remainder vests in 36 equal monthly installments after first anniversary
Key Terms
Employee Stock Option, exercise price, grant date, vesting, +1 more
5 terms
Employee Stock Option financial
"security_title: "Employee Stock Option (Right to Buy)""
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
exercise price financial
"conversion_or_exercise_price: "26.7700""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
grant date financial
"shares subject to the option award shall vest on the first anniversary of the grant date"
The grant date is the day a company formally gives an employee or contractor the right to receive stock-based compensation, such as stock options or restricted shares. It matters to investors because it fixes key terms—like the price, the start of the ownership clock, and when the award will affect the company’s financial statements and share count—so it can influence dilution, reported expenses, and potential future selling pressure.
vesting financial
"shares subject to the option shall vest in thirty-six (36) equal monthly installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Evommune (EVMN) disclose in this Form 4?
Evommune disclosed that Chief Business & Legal Officer Gregory S. Moss received an employee stock option grant for 115,279 shares. These options allow him to buy Evommune common stock at a fixed price in the future, subject to vesting conditions and an expiration date.
What is the exercise price of Gregory Moss’s Evommune (EVMN) stock options?
The options have an exercise price of $26.77 per share. This means Moss can buy Evommune common stock at $26.77 for each optioned share once they vest and before they expire, regardless of the market price at that time.
When do Gregory Moss’s Evommune (EVMN) stock options vest?
One fourth of the option shares vest on the first anniversary of the grant date. The remaining shares then vest in 36 equal monthly installments, as long as Moss maintains continuous service with Evommune through each applicable vesting date.
When do Gregory Moss’s Evommune (EVMN) stock options expire?
The options expire on April 15, 2036. After that date, any unexercised options will no longer be exercisable, so Moss must exercise any vested options he wishes to use before the stated expiration date in the grant terms.
Is Gregory Moss’s Evommune (EVMN) option grant an open-market stock purchase?
No, this is a compensation-related stock option grant, not an open-market share purchase. The options were awarded at no cost per option and give Moss the right to buy shares later at $26.77, subject to vesting and expiration conditions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates